Zeng S, Yang H, Wang B, Xie Y, Xu K, Liu L, et al. The MORC2 p.S87L mutation reduces proliferation of pluripotent stem cells derived from a patient with the spinal muscular atrophy-like phenotype by inhibiting proliferation-related signaling pathways. Neural Regen Res. 2024;19:205-211 pubmed publisher

Baik J, Ortiz Cordero C, Magli A, Azzag K, Crist S, Yamashita A, et al. Establishment of Skeletal Myogenic Progenitors from Non-Human Primate Induced Pluripotent Stem Cells. Cells. 2023;12: pubmed publisher

Perdig xe3 o P, Ollington B, Sai H, Leung A, Sacristán Reviriego A, van der Spuy J. Retinal Organoids from an AIPL1 CRISPR/Cas9 Knockout Cell Line Successfully Recapitulate the Molecular Features of LCA4 Disease. Int J Mol Sci. 2023;24: pubmed publisher

Oliveira A, Martins S, Cammarata G, Martins M, Cardoso A, Almeida M, et al. Generation and Characterization of Novel iPSC Lines from a Portuguese Family Bearing Heterozygous and Homozygous GRN Mutations. Biomedicines. 2022;10: pubmed publisher

Molugu K, Battistini G, Heaster T, Rouw J, Guzman E, Skala M, et al. Label-Free Imaging to Track Reprogramming of Human Somatic Cells. GEN Biotechnol. 2022;1:176-191 pubmed publisher

Molugu K, Harkness T, Carlson Stevermer J, Prestil R, Piscopo N, Seymour S, et al. Tracking and Predicting Human Somatic Cell Reprogramming Using Nuclear Characteristics. Biophys J. 2019;: pubmed publisher

Howden S, Thomson J, Little M. Simultaneous reprogramming and gene editing of human fibroblasts. Nat Protoc. 2018;13:875-898 pubmed publisher

Howden S, Maufort J, Duffin B, Elefanty A, Stanley E, Thomson J. Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts. Stem Cell Reports. 2015;5:1109-1118 pubmed publisher